Derek Hicks
Net worth: 842 483 $ as of 30/05/2026
Net worth: 842 483 $ as of 30/05/2026
Derek Hicks currently works at Rezo Therapeutics, Inc., as Chief Executive Officer from 2025.
Mr. Hicks also formerly worked at Spark Therapeutics, Inc., as Head-Business Development from 2020 to 2021 and Intellia Therapeutics, Inc., as Chief Business Officer & Executive Vice President.
Mr. Hicks received his undergraduate degree and graduate degree from the University of Connecticut and Masters Business Admin degree from Kelley School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/01/2025 | 59,878 ( 0.04% ) | 842 483 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Chief Executive Officer | 11/08/2025 |
| Companies | Position | End |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 30/11/2021 |
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions